6.17
Katherine Unger Baillie
Science News Officer
kbaillie@upenn.edu
Cancer Research
Better prognosticating for dogs with mammary tumors
For dogs with mammary tumors, a course of treatment can depend on a variety of factors, some of which may seem to contradict one another. A new system developed by Penn Vet’s Karin Sorenmo and colleagues can make determining a prognosis and making treatment decisions an easier task.
Finding clues to a genetic link to treatment for BRCA1/2 breast cancer patients
New research could shape treatment strategies and clinical trial design for patients with BRCA1 and BRCA2-related breast cancers.
Proton therapy side-effects found fewer than conventional radiation
In the largest study of its kind, Penn researchers compare overall adverse events of proton and photon therapies.
Compound’s benefits aren’t tied to the body clock
New research from Penn Medicine overturns what was previously known about a compound associated with reductions in obesity and diabetes risk.
Cancer screening rates decline when patients see doctors later in day
Compared to patients who see their primary care doctor earlier in the day, cancer screening rates decline significantly as the day goes on, according to a new study from researchers in the Perelman School of Medicine and Wharton School.
The cancer-body clock connection
Researchers at the Perelman School of Medicine show how disruptions to the circadian rhythm influence tumor growth and cancer treatment.
Two Penn faculty elected to the National Academy of Sciences
Eugene Mele of the School of Arts and Sciences and Nancy Speck of the Perelman School of Medicine are welcomed into the Academy for their “distinguished and continuing achievements in original research.”
Expanding opportunities to leverage science in the clinic
Patricia Corby, who recently joined the School of Dental Medicine as associate dean for translational research, is bringing her research to bear for cancer patients undergoing radiation, while looking to advance clinical research School-wide.
Topical targeted therapies show promise in treatment of skin cancer
A Penn study finds fewer side effects with small-molecule kinase inhibitors compared to standard ointment when treating precancerous skin lesions.
The Power of Penn at the Met
One year into the Power of Penn campaign, President Amy Gutmann hosted a panel discussion with three professors to usher in another year of inclusion, innovation, and impact on a local and global scale.
Media Contact
Experts
In the News
HealthDay News
For Breast Cancer Patients, Less Time on Hormonal Meds?
Susan Domchek of the Perelman School of Medicine and the Abramson Cancer Center comments on hormonal therapy.
FULL STORY →
Nature
Acupuncture in Cancer Study Reignites Debate About Controversial Technique
Rollin Gallagher of the Perelman School of Medicine comments on a clinical trial that focused on whether acupuncture can relieve pain in cancer patients.
FULL STORY →